01—Abstract
Summary
Summary of the 8-K filed October 30, 2024. Cited figures are marked; the original filing is the authoritative source.
Bunge Global SA (NYSE: BG) disclosed on October 30, 2024 that its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), further extended the expiration date of its exchange offers and consent solicitations for four series of notes issued by Viterra Finance B.V.
(Viterra's 2026, 2027, 2031 and 2032 notes, totaling roughly $1.95 billiona in new Bunge notes available). The expiration date moved from October 31, 2024 to January 2, 2025, and BLFC has signaled it will keep extending the date until the Viterra acquisition closes. The exchanges are conditioned on closing the Viterra Business Combination, which is itself awaiting antitrust approvals; management expects the remaining approvals and closing in the next several months.
The consent solicitations have already succeeded in getting the required consents for amendments to the Viterra indentures, executed September 23, 2024. These amendments would strip out certain covenants, restrictive provisions and events of default, and would release the parent guarantees from Viterra Limited and Viterra B.V. However, the amendments only become operative at settlement of the exchanges, which is expected within two business days after the expiration date.
Tender participation as of 6:00 a.m. on October 30, 2024 was high across all series, ranging from 94.4%b of the 2026 notes to 99.3% of the 2031 notes, which suggests that most holders are choosing to exchange into Bunge-guaranteed paper. For investors, the filing is mainly procedural, but it matters for debt structure. If the Viterra deal closes, Bunge would absorb Viterra's debt and replace most of it with Bunge-guaranteed notes while removing the Viterra-level guarantees and covenant protections for remaining holders.
The filing notes that holders who do not exchange may face reduced liquidity and weaker protections. The filing also contains standard forward-looking statement warnings about Bunge's ability to service debt and access capital.
02—Key points
Key Highlights
- Extension: The expiration date for the Viterra notes exchange offers moved from October 31, 2024 to 5:00 p.m. NYC time on January 2, 2025, and may be extended again if the Viterra acquisition has not closed by then.
- Scale: Up to $1.95 billion aggregate principal of new Bunge-guaranteed notes is available in exchange for four Viterra note series, with cash also offered as consideration.
- High participation: As of October 30, 2024, 94.4% of the 2026 notes ($566.3M of $600M), 97.1% of the 2027 notes ($437.0M of $450M), 99.3% of the 2031 notes ($596.1M of $600M) and 98.3% of the 2032 notes ($295.0M of $300M) had been tendered.
- Proposed amendments: Consents already obtained (September 20, 2024) would eliminate certain covenants, restrictive provisions and events of default, and release Viterra and Viterra B.V. guarantees, but only once the exchange settles.
- Deal dependency: Exchanges and consent solicitations are conditioned on closing Bunge's pending Viterra acquisition, which requires antitrust approvals. Bunge expects closing within several months.
- Investor risk: Non-exchanging holders may face reduced liquidity and weaker creditor protections after the amendments take effect.
03—Questions
Frequently Asked Questions
Why was the expiration date extended, and will it be extended again?
The extension to January 2, 2025 reflects that the Viterra business combination had not yet closed and was still awaiting regulatory approvals. BLFC has said that if the combination is not expected to close by the expiration date, it will extend the date again and give advance notice.
What do noteholders receive in the exchange?
Eligible holders who tender Viterra notes can receive new notes issued by BLFC and guaranteed by Bunge, up to $1.95 billion in aggregate principal, along with cash. The filing does not give the exact exchange ratio, so investors should review the Statement dated September 9, 2024.
What changes for holders who do not exchange their notes?
The amendments would remove many covenants and events of default and release the Viterra and Viterra B.V. guarantees. Holders who remain in the old notes would therefore have fewer protections and possibly less trading liquidity, as the filing itself warns.
Is the exchange certain to happen?
No. The exchange offers and consent solicitations are conditioned on the Viterra acquisition closing, and that closing depends on antitrust approvals and other customary conditions. The acquisition does not depend on the exchange, so the deal could close without the exchange completing.
Does this filing change Bunge's financial results or outlook?
The filing does not report new financial results or a change to guidance. It is a procedural update on debt exchange mechanics tied to the Viterra acquisition, although it shows high tender levels and signals the future debt structure of the combined company.
04—Continue